The augementation hypothesis for improvement of antidepressant therapy: Is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?

Author： Kinney Gene   Taber Matthew   Gribkoff Valentin  

Publisher： Humana Press, Inc

ISSN： 0893-7648

Source： Molecular Neurobiology, Vol.21, Iss.3, 2000-01, pp. : 137-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quinoxalin-2-carboxamides: synthesis and pharmacological evaluation as serotonin type-3 (5-HT3) receptor antagonists

By Mahesh Radhakrishnan   Devadoss Thangaraj   Pandey Dilip Kumar   Yadav Shushil Kumar  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 26, Iss. 5, 2011-10 ,pp. : 610-615

Informa Healthcare

Access to resources Recommend Favorite

Specific oligomerization of the 5-HT1A receptor in the plasma membrane

By Woehler Andrew   Wlodarczyk Jakub   Ponimaskin Evgeni  

Glycoconjugate Journal, Vol. 26, Iss. 6, 2009-08 ,pp. : 749-756

Springer Publishing Company

Access to resources Recommend Favorite

Quantitative assay of 5-HT1A receptor gene expression in the brain

By Naumenko V.   Kulikov A.  

Molecular Biology, Vol. 40, Iss. 1, 2006-01 ,pp. : 30-36

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

On the role of the selective silencer Freud-1 in the regulation of the brain 5-HT 1A receptor gene expression

By Naumenko V.   Osipova D.   Tsybko A.  

Molecular Biology, Vol. 44, Iss. 5, 2010-10 ,pp. : 795-800

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Dopamine D1 receptor and serotonin 5-HT1A receptor agonist effects of the natural product (–)-stepholidine: molecular modelling and dynamics simulations

By Gong Yunguo   Fu Wei   Chen Kaixian  

Molecular Simulation, Vol. 38, Iss. 12, 2012-10 ,pp. : 970-979

Taylor & Francis Ltd

Access to resources Recommend Favorite